The sugar-free formula makes it a light option that easily fits into a sports routine or weight loss goal
A total of 3286 patients had taken a GLP-1 RA and 1692 had taken an SGLT2i at some point in time
From its initial use in the treatment of type 2 diabetes to its expansion to 12 indications such as obesity, cardiovascular disease, chronic kidney disease, and metabolic dysfunction related fatty liver disease (MASLD), the annual sales of GLP-1 drugs exceeded 100 billion dollars, and its research and development funding reached a historical peak of 21.72 million dollars in 2025
2 yrsCN4.6/5.0 10% Reorder rate 691 Interested customers Market Trends of 30000 mg glutathione The global market for high-dose glutathione supplements, including 30,000 mg formulations, is experiencing rapid growth driven by rising demand for advanced antioxidant and skin-brightening solutions
Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human